Patents Assigned to SIRIUS THERAPEUTICS, INC.
  • Patent number: 11981703
    Abstract: Disclosed are polynucleotide constructs having a strand linked to a moiety carrying one or more auxiliary moieties. Also disclosed are polynucleotide constructs interrupted with a sugar analogue, and polynucleotide constructs with stereochemical{circumflex over (?)} enriched phosphorothioates. The polynucleotide constructs may be provided as hybridized polynucleotide constructs. Also featured are methods of delivery a polynucleotide construct to a cell and methods of reducing the expression of a protein in a cell by contacting the cell with the disclosed polynucleotide construct or hybridized polynucleotide construct.
    Type: Grant
    Filed: August 17, 2017
    Date of Patent: May 14, 2024
    Assignee: SIRIUS THERAPEUTICS, INC.
    Inventors: Sukumar Sakamuri, Curt W. Bradshaw, Laxman Eltepu, Bryan R. Meade, Son Lam
  • Patent number: 11597744
    Abstract: Disclosed are chiral phosphoramidite auxiliary compositions for diastereoselective synthesis of stereochemically enriched oligonucleotides, and nucleoside phosphoramidite compounds comprising the same. Exemplary structures of the chiral phosphoramidite auxiliary compositions include Formulas (IA) and (IB).
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: March 7, 2023
    Assignee: SIRIUS THERAPEUTICS, INC.
    Inventors: Sukumar Sakamuri, Curt W. Bradshaw, Dingguo Liu, Laxman Eltepu